Organon (OGN) stock in focus as the Merck (MRK) spinoff buys rights to Biogen's (BIIB) biosimilar Tofidence, targeting ...

Organon (OGN) announced that it has acquired from Biogen (BIIB) regulatory and commercial rights in the U.S. for Tofidence, a biosimilar to ...

Shares of Biogen Inc. BIIB shed 1.11% to $136.84 Monday, on what proved to be an all-around favorable trading session for the ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

Biogen Inc. has a 12 month low of $128.51 and a 12 month high of $238.00. The firm has a market cap of $21.01 billion, a price-to-earnings ratio of 12.83, a PEG ratio of 1.51 and a beta of 0.01.

If you buy something, we may earn an affiliate commission. Before we dive into our picks for the best bed in a box, a quick history lesson is in order. In the aughts, a red-caped magician called ...

Lisa Shafer, a vice president at biotech firm Biogen, will keynote the conference. Shafer has held executive management positions at key pharmaceutical firms such as Teva as well as neurotech ...

NEW YORK, N.Y., March 17, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Eighth ...

NEW YORK, N.Y., March 17, 2025 -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Eighth Annual Bioelectronic ...